American Cartel by Scott Higham

American Cartel

Inside the Battle to Bring Down the Opioid Industry

Scott Higham, Sari Horwitz

Grand Central Publishing · Print & ebook · July 12, 2022

The definitive investigation and exposé of how some of the nation's largest corporations created and fueled the opioid crisis—from the Pulitzer Prize-winning Washington Post reporters who first uncovered the dimensions of the deluge of pain pills that ravaged the country and the complicity of a near-omnipotent drug cartel.

Buy on Amazon

We earn from qualifying purchases.

Who it’s for
A grim, high-stakes account with the clipped momentum of investigative reportage.
Genres
White-Collar Crime, Drugs & the Law, Pharma & Biotech Industry
Published
Grand Central Publishing, July 12, 2022

Nearest books

Matched by what the books are about, then ordered by what their readers also loved.

  1. Raising LazarusBeth Macy74% match
  2. These Are the PlunderersGretchen Morgenson, Joshua Rosner54% match
  3. The Last KiloT. J. English55% match
  4. Profit and PunishmentTony Messenger53% match

For younger readers: Heroine

Start with three books, and this one can be the first.

Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.

Start with this book

About this book

The definitive investigation and exposé of how some of the nation's largest corporations created and fueled the opioid crisis—from the Pulitzer Prize-winning Washington Post reporters who first uncovered the dimensions of the deluge of pain pills that ravaged the country and the complicity of a near-omnipotent drug cartel.

Continue reading

AMERICAN CARTEL is an unflinching and deeply documented dive into the culpability of the drug companies behind the staggering death toll of the opioid epidemic. It follows a small band of DEA agents led by Joseph Rannazzisi, a tough-talking New Yorker who had spent a storied thirty years bringing down bad guys; along with a band of lawyers, including West Virginia native Paul Farrell Jr., who fought to hold the drug industry to account in the face of the worst man-made drug epidemic in American history. It is the story of underdogs prevailing over corporate greed and political cowardice, persevering in the face of predicted failure, and how they found some semblance of justice for the families of the dead during the most complex civil litigation ever seen. The investigators and lawyers discovered hundreds of thousands of confidential corporate emails and memos during courtroom combat with legions of white-shoe law firms defending the opioid industry. One breathtaking disclosure after another—from emails that mocked addicts to invoices chronicling the rise of pill mills—showed the indifference of big business to the epidemic’s toll. The narrative approach echoes such work as A Civil Action and The Insider, moving dramatically between corporate boardrooms, courthouses, lobbying firms, DEA field offices, and Capitol Hill while capturing the human toll of the epidemic on America’s streets. AMERICAN CARTEL is the story of those who were on the front lines of the fight to stop the human carnage. Along the way, they suffer a string of defeats, some of their careers destroyed by the very same government officials who swore to uphold the law before they begin to prevail over some of the most powerful corporate and political influences in the nation.

Hard Truths

A grim, high-stakes account with the clipped momentum of investigative reportage.

Come here for

  • hard-nosed industry scrutiny
  • serious, reportorial cadence

Expect

  • opioid crisis and accountability
  • prestige nonfiction with edge

Where it sits

White-Collar Crime41%
Pharma & Biotech Industry31%
Drugs & the Law26%

Percentages are BookFrontier’s reading of the book.

Publisher categories

  • Pharma & Biotech Industry
  • Medical Law & Policy
  • Public Health
  • White-Collar Crime
Authors
Scott Higham, Sari Horwitz
Publisher
Grand Central Publishing
Published
July 12, 2022
Format
Print & ebook
Reading lane
Pharma & Biotech Industry